> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Comments Sought on Biologic Manufacturing Arrangements
- URL: https://www.fdaweb.com/comments-sought-on-biologic-manufacturing-arrangements/
- Published: 2017-08-08T12:00:00.000Z
- Updated: 2026-09-14T22:39:33.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5139332

*Federal Register* notice: FDA is seeking comments on an information collection extension for its “Guidance for Industry: Cooperative Manufacturing Arrangements for Licensed Biologics.” The document provides information concerning cooperative manufacturing arrangements applicable to biological products subject to licensure under section 351 of the Public Health Service Act. It addresses several types of manufacturing arrangements (i.e., short supply arrangements, divided manufacturing arrangements, shared manufacturing arrangements, and contract manufacturing arrangements) and describes certain reporting and recordkeeping responsibilities associated with these arrangements. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-08-07/pdf/2017-16564.pdf?ref=fdaweb.com).